Index of reports
> Cases with Pyrexia (24)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Campath side effects in male
Reported by a consumer/non-health professional from France on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend
Possible Campath side effects in male
Reported by a consumer/non-health professional from France on 2012-08-17
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Prostatitis, Adenovirus Infection, Dysuria, Cystitis Haemorrhagic, Pollakiuria, Human Polyomavirus Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Vfend; Folic Acid; Bactrim
Possible Campath side effects in female
Reported by a consumer/non-health professional from Germany on 2012-07-06
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, bid
Start date: 2009-07-23
Campath
Dosage: 20 mg, qd
Start date: 2009-07-07
Campath
Dosage: 30 mg, qd
Start date: 2009-08-06
End date: 2009-08-06
Campath
Dosage: 30 mg, qd
Start date: 2009-09-11
End date: 2009-10-22
Campath
Dosage: 10 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-20
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-21
Cyclophosphamide
Dosage: 1250 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-07
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-07
Doxorubicin HCL
Dosage: 80 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-21
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-23
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-20
Filgrastim
Dosage: 3000 iu, unk
Start date: 2009-07-26
End date: 2009-08-27
Filgrastim
Dosage: unk on days 4 through 13 of course 5
Start date: 2009-08-20
Filgrastim
Dosage: unk on days 4 through 12 of course 6
Start date: 2009-09-08
Filgrastim
Dosage: unk on days 4, 5, 6 of course 1
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Filgrastim
Dosage: unk on days 4 through 15 of course 2
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 8 and day 13 of course 3
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
Start date: 2009-08-06
Filgrastim
Dosage: 30000 iu, qd
Start date: 2009-09-11
End date: 2009-09-19
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-09-11
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-07
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-08-06
End date: 2009-08-10
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-23
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2009-09-08
End date: 2009-09-08
Vincristine
Dosage: 2 mg, once
Start date: 2009-06-23
Vincristine
Dosage: 1 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-23
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-07
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-21
Vincristine
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva
Possible Campath side effects in female
Reported by a physician from Germany on 2012-04-16
Patient: female, weighing 69.7 kg (153.3 pounds)
Reactions: Cardiac Failure, C-Reactive Protein Increased, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-01-09
End date: 2012-02-20
Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Levothyroxine Sodium; Ramipril Plus
Possible Campath side effects in male
Reported by a individual with unspecified qualification from United States on 2012-03-27
Patient: male, weighing 119.0 kg (261.8 pounds)
Reactions: Nasopharyngitis, Dyspnoea, Hypotension, Pulmonary Embolism, Acidosis, Oropharyngeal Pain, Pyrexia, Cardio-Respiratory Arrest, Hypoxia, Acute Respiratory Distress Syndrome, Septic Shock, Respiratory Syncytial Virus Test Positive, Lung Infiltration, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 360 mg
Cyclophosphamide
Dosage: 1404 mg
Pentostatin
Dosage: 9.36 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 878 mg
Other drugs received by patient: Bactrim DS; Acyclovir
Possible Campath side effects in female
Reported by a physician from Germany on 2012-03-20
Patient: female, weighing 69.7 kg (153.3 pounds)
Reactions: C-Reactive Protein Increased, Cardiac Failure, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-01-09
End date: 2012-02-20
Other drugs received by patient: Levothyroxine Sodium; Acyclovir; Ramipril Plus; Cotrim Forte EU RHO; Ciprofloxacin
Possible Campath side effects in female
Reported by a physician from Germany on 2012-03-12
Patient: female, weighing 160.0 kg (352.0 pounds)
Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-01-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Neulasta
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-02-09
End date: 2012-02-20
Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus; Levothyroxine Sodium
Possible Campath side effects in female
Reported by a physician from Germany on 2012-03-08
Patient: female, weighing 160.0 kg (352.0 pounds)
Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-01-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Neulasta
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-02-09
End date: 2012-02-20
Other drugs received by patient: Ciprofloxacin; Levothyroxine Sodium; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus
Possible Campath side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05
Patient: 54 year old male, weighing 119.0 kg (261.8 pounds)
Reactions: Nasopharyngitis, Dyspnoea, Oropharyngeal Pain, Pyrexia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acyclovir Sodium
Dosage: 100 mg mwf cycle 1, then 878 d1 cycle 2-6
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Campath
Dosage: 30 mg, tiw x 4 weeks, subcutaneous
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-31
End date: 2011-11-25
Cytoxan
Dosage: 1404 mg on d1 c1-6, wks 1, 5, 9, 13, 17 and 21, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Nipent
Dosage: 9.36 mg on day 1 c1-6, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Other drugs received by patient: Bactrim DS; Acyclovir
Possible Campath side effects in female
Reported by a physician from Germany on 2012-02-29
Patient: female, weighing 79.0 kg (173.8 pounds)
Reactions: Dyspnoea, Lung Disorder, Pyrexia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, once daily every 15 days
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-12-09
End date: 2011-12-23
Dexamethasone
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Neulasta
Dosage: unk
Indication: Neutropenia
Other drugs received by patient: Fluoxetine; Crestor; Vitamin D; Acyclovir; Nexium; Levothyroxine Sodium; Pentacarinat
Possible Campath side effects in male
Reported by a physician from United States on 2012-02-21
Patient: male, weighing 119.0 kg (261.8 pounds)
Reactions: Dyspnoea, Nasopharyngitis, Oropharyngeal Pain, Pyrexia, Hypoxia, Respiratory Syncytial Virus Test Positive, Lung Infiltration, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 360 mg
Cyclophosphamide
Dosage: 1404 mg
Pentostatin
Dosage: 9.36 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 878 mg
Other drugs received by patient: Bactrim DS; Acyclovir
Possible Campath side effects in male
Reported by a consumer/non-health professional from Germany on 2012-02-15
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-12
End date: 2011-12-09
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-12
End date: 2011-11-30
Neulasta
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-10-12
End date: 2011-12-09
Other drugs received by patient: Tamsulosin HCL; Voriconazole; Cotrim; Valcyte; Metoclopramide
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-08
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-12
End date: 2011-12-09
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-12
End date: 2011-11-30
Neulasta
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-10-12
End date: 2011-12-09
Other drugs received by patient: Cotrim; Valcyte; Voriconazole; Metoclopramide; Tamsulosin HCL
Possible Campath side effects in male
Reported by a physician from France on 2012-01-30
Patient: male
Reactions: Vomiting, Chills, Rash Erythematous, Pyrexia, Disease Progression, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2010-05-03
End date: 2010-05-03
Campath
Dosage: unk
Start date: 2010-06-14
End date: 2010-06-14
Campath
Dosage: unk
Start date: 2010-06-07
End date: 2010-06-07
Possible Campath side effects in
Reported by a physician from Netherlands on 2012-01-09
Patient:
Reactions: Fatigue, General Physical Health Deterioration, Pyrexia, Decreased Appetite
Drug(s) suspected as cause:
Campath
Dosage: unk, 3 to 30 mg
Indication: Hepatosplenic T-Cell Lymphoma
Campath
Dosage: 30 mg unk, 11 doses administered
Possible Campath side effects in 64 year old male
Reported by a physician from Italy on 2012-01-03
Patient: 64 year old male
Reactions: Visceral Leishmaniasis, Pancytopenia, Pyrexia, Splenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Possible Campath side effects in male
Reported by a physician from Germany on 2011-12-20
Patient: male
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-12
End date: 2011-12-09
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-12
End date: 2011-11-30
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-10-12
End date: 2011-12-09
Other drugs received by patient: Metoclopramide; Valcyte; Voriconazole; Cotrim; Tamsulosin HCL
Possible Campath side effects in female
Reported by a physician from Germany on 2011-12-15
Patient: female, weighing 71.0 kg (156.2 pounds)
Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 unk, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-16
Dexamethasone
Dosage: 40 unk, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-10
Pegfilgrastim
Dosage: 6 unk, unk
Indication: Neutropenia
Start date: 2011-11-07
End date: 2011-11-07
Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acyclovir; Levofloxacin; Acetylcysteine
Possible Campath side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07
Patient: 61 year old male
Reactions: Cardiac Failure, Dehydration, Skin Lesion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Possible Campath side effects in female
Reported by a physician from Germany on 2011-11-28
Patient: female, weighing 71.0 kg (156.2 pounds)
Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 unk, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-16
Dexamethasone
Dosage: 40 unk, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-10
Pegfilgrastim
Dosage: 6 unk, unk
Indication: Neutropenia
Start date: 2011-11-07
End date: 2011-11-07
Other drugs received by patient: Levofloxacin; Acetylcysteine; Acyclovir; Cotrim; Pantoprazole Sodium
Possible Campath side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-02
Patient: 62 year old male
Reactions: Epstein-Barr Virus Infection, Dyspnoea, Dysphagia, Hypoxia, Epstein-Barr Virus Associated Lymphoproliferative Disorder, Pyrexia, Oropharyngeal Pain, Sinus Congestion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Indication: Prophylaxis Against Graft Versus Host Disease
Campath
Fludara
Indication: Prophylaxis Against Graft Versus Host Disease
Fludara
Other drugs received by patient: Melphalan Hydrochloride; Melphalan Hydrochloride; Cyclosporine
Possible Campath side effects in 42 year old
Reported by a physician from Germany on 2011-11-01
Patient: 42 year old
Reactions: Death, Herpes Simplex, Sepsis, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Campath
Other drugs received by patient: Busulfan; Fluconazole; Acyclovir; Trimethoprim; Basiliximab; Anti-Thymocyte Globulin NOS; Sulphamethoxazole; Etanercept; Daclizumab; Methotrexate; Cyclophosphamide; Mycophenolate Mofetil; Cyclosporine
Possible Campath side effects in 62 year old male
Reported by a physician from United Kingdom on 2011-10-31
Patient: 62 year old male
Reactions: Epstein-Barr Virus Infection, Dysphagia, Dyspnoea, Hypoxia, Epstein-Barr Virus Associated Lymphoproliferative Disorder, Oropharyngeal Pain, Pyrexia, Sinus Congestion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 10 mg qd, days -1 to -3
Indication: Stem Cell Transplant
Campath
Indication: Refractory Anaemia
Fludara
Dosage: unk
Indication: Stem Cell Transplant
Fludara
Indication: Refractory Anaemia
Melphalan Hydrochloride
Dosage: unk
Indication: Stem Cell Transplant
Melphalan Hydrochloride
Indication: Refractory Anaemia
Other drugs received by patient: Cyclosporine
Possible Campath side effects in 42 year old
Reported by a physician from Germany on 2011-10-14
Patient: 42 year old
Reactions: Death, Herpes Simplex, Sepsis, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Campath
Other drugs received by patient: Anti-Thymocyte Globulin NOS; Trimethoprim; Mycophenolate Mofetil; Etanercept; Basiliximab; Methotrexate; Acyclovir; Cyclosporine; Daclizumab; Sulphamethoxazole; Fluconazole; Cyclophosphamide; Busulfan
|